Atlas Trials

Open Label Pharmacokinetic Study of SAR302503 in Subjects With Renal Impairment

Clinical trial NCT01763190 · COMPLETED

Trial details

NCT number
NCT01763190
Sponsor
Bristol-Myers Squibb
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Renal Impairment
Start date
2012-11-01
Primary completion
2013-07-01
Enrollment
36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.